Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Mikael Dolsten MD, PhD
Age : 59
Public asset : 12,213,757 USD
Linked companies : Pfizer Inc. - Karyopharm Therapeutics Inc
Dr. Mikael Dolsten is an Independent Director at Karyopharm Therapeutics, Inc., a President-Worldwide Research & Development at Pfizer Inc., a Member at Government-University-Industry Research Roundtable and a Member at Royal Swedish Academy of Engineering Sciences.

He is on the Board of Directors at Karyopharm Therapeutics, Inc., PhRMA Foundation and New York Academy of Sciences. Dr. Dolsten was previously employed as a Senior Vice President by Wyeth Corp., a President by Wyeth Research, a Principal by OrbiMed Advisors LLC, a Partner by OrbiMed Advisors Private Equity, an EVP, Global Head-Pharma Research & Discovery by Boehringer Ingelheim Pharmaceuticals, Inc., a Trustee by New York Hall of Science, and a Member-Benefits, Law & Regulatory Committee by Wyeth Pharmaceuticals LLC.

He received his doctorate degree from the University of Lund.

Current positions of Mikael Dolsten MD, PhD 
NameTitle Since
Karyopharm Therapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2015
New York Academy of Sciences Member-Governors Board -
PhRMA Foundation Director -
Pfizer Inc.
President-Worldwide Research & Development 2009
Royal Swedish Academy of Engineering Sciences Member -
Government-University-Industry Research Roundtable Member -

Holdings of Mikael Dolsten MD, PhD 
Pfizer (PFE)
339,9320.0058%12,213,757 USD
Karyopharm Therapeutics Inc (KPTI)
Biotechnology & Medical Research
00.0000%0 USD

Mikael Dolsten MD, PhD: Personal Network 

Most Read News 
06/19MARTIN WINTERKORN : Head of Volkswagen's Audi arrested in Germany over diesel scandal
06/19ELON MUSK : CEO Musk emails staff alleging employee 'sabotage'
06/14BILL GATES : Hong Kong market could open cash flood gates for U.S. biotechs
06/14ELON MUSK : Musk's Boring Company wins bid to build high-speed system in Chicago
06/13ELON MUSK : Elon Musk buys 72,500 of Tesla shares
04:04pRUPERT MURDOCH : Fox, Disney Reach Sweetened Merger Agreement -- 6th Update
06/14LI KA-SHING : Li Ka-shing Scion Is Set To Expand His Empire -- WSJ
06/19WOLFGANG PORSCHE : Audi CEO crisis threatens fragile truce among VW stakeholders
06/13LI KA-SHING : Hong Kong's CK Infrastructure Bids More Than $9 Billion for Australian Pipeline Operator APA -- Update
06/13MARTIN SORRELL : Sorrell haunts WPP as shareholders rebel over farewell package
More news

© 2018 People and Ownership :   
Mikael Dolsten MD, PhD : Connections 
Harvard Partners Center for Genetics & Genomics
Delphi Management Partners VIII LLC
Delphi Ventures III LP
National Venture Capital Association
Relypsa, Inc.
Delphi Management Partners VII LLC
Metamark Genetics, Inc.
Delphi Ventures, Inc.
Vicarious Surgical, Inc.

Popular Business Leaders 
Paul Achleitner William Ackman Frank Appel Jeff Bezos Lloyd Blankfein Michael Bloomberg Vincent Bolloré Warren Buffett Vittorio Colao Tim Cook Serge Dassault Oleg Deripaska John Edwards Bill Gates Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Arnaud Lagardère Jack Ma Sergio Marchionne Laurent Mignon Lakshmi Mittal Rupert Murdoch Elon Musk Peter Nicholas Xavier Niel Frédéric Oudéa James Packer Gavin Patterson Georges Plassat Wolfgang Porsche Roberto Quarta Sumner Redstone Alexandre Ricard Wilbur Ross Howard Schultz Masayoshi Son George Soros Martin Sorrell Rupert Stadler Tidjane Thiam Viktor Vekselberg Christophe Weber John Williamson Thomas Wilson Martin Winterkorn Steve Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders